ETC
BPMC

Exchange Traded Concepts’s Blueprint Medicines BPMC Stock Holding History

Exchange Traded Concepts’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,383
Closed -$122K – 1419
2025
Q1 		$122K Sell
1,383
-626
-31% -$61.1K ﹤0.01% 1082
2024
Q4 		$175K Sell
2,009
-22
-1% -$2.02K ﹤0.01% 1020
2024
Q3 		$188K Sell
2,031
-505
-20% -$50.2K ﹤0.01% 987
2024
Q2 		$273K Sell
2,536
-749
-23% -$75K 0.01% 837
2024
Q1 		$312K Buy
3,285
+515
+19% +$44.2K 0.01% 785
2023
Q4 		$256K Buy
2,770
+703
+34% +$45.5K 0.01% 768
2023
Q3 		$104K Sell
2,067
-371
-15% -$19.8K ﹤0.01% 879
2023
Q2 		$154K Buy
+2,438
New +$133K ﹤0.01% 833
2022
Q3 		– Sell
-9,348
Closed -$472K – 1170
2022
Q2 		$472K Buy
+9,348
New +$548K 0.01% 534
2022
Q1 		– Sell
-661
Closed -$71K – 1219
2021
Q4 		$71K Buy
661
+225
+52% +$23.5K ﹤0.01% 897
2021
Q3 		$45K Buy
436
+121
+38% +$11.3K ﹤0.01% 856
2021
Q2 		$28K Buy
+315
New +$28.9K ﹤0.01% 934
2021
Q1 		– Sell
-6,016
Closed -$675K – 1052
2020
Q4 		$675K Sell
6,016
-2,428
-29% -$256K 0.03% 291
2020
Q3 		$783K Buy
+8,444
New +$650K 0.04% 192

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Exchange Traded Concepts's BPMC Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 1,383 shares — an estimated $122K sold.

Exchange Traded Concepts first reported a position in BPMC in Q3 2020 and held it in 14 quarters. The position peaked at $783K in Q3 2020. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 1,383 Blueprint Medicines shares in Q2 2025, an estimated $122K.
  • Exchange Traded Concepts first reported a position in Blueprint Medicines in Q3 2020 and held it in 14 quarters.
  • Exchange Traded Concepts's Blueprint Medicines position peaked at $783K in Q3 2020.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.